SOUTH SAN FRANCISCO, Calif. (AP) _ Veracyte Inc. (VCYT) on Wednesday reported a loss of $8.2 million in its first quarter.
The South San Francisco, California-based company said it had a loss of 24 cents per share.
The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 24 cents per share.
The molecular diagnostic company posted revenue of $16.4 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $18.1 million.
Veracyte expects full-year revenue in the range of $76 million to $84 million.
Veracyte shares have climbed 1 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $7.83, a rise of 40 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VCYT at https://www.zacks.com/ap/VCYT
Keywords: Veracyte, Earnings Report